业界动态国内医卫资讯
与B12及其他添加剂共同配制的复方GLP-1药物
Medscape News · 2026-10-29 15:37
摘要
这些复方产品在上市前未经FDA评估，因此其成分、稳定性及临床后果在很大程度上尚不明确。Medscape医学新闻
English
Compounded GLP-1s Coformulated With B12, Other Additives
These combination products are not evaluated by the FDA before marketing, so their composition, stability, and clinical consequences are largely unknown. Medscape Medical News